Concerning the anti-major histocompatibility complex approach to HIV type 1 vaccine design (multiple letters)

AIDS Research and Human Retroviruses

Volumn 14, Issue 7, 1998, Pages 541-544

  Luscher, M A ^a   Dela Cruz, C S ^a   MacDonald, K S ^a   Barber, B H ^a   Polyanska, N ^a   Banks, J ^a   Sharpe, S ^a   Dennis, M ^a   Cook, N ^a   Hall, G ^a   Leech, S ^a   Cranage, M P ^a   Stott, E J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BETA 2 MICROGLOBULIN; HLA A2 ANTIGEN; HLA B27 ANTIGEN; HLA B7 ANTIGEN; HLA C ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; PLASMID DNA; QUIL A;

ANTIBODY RESPONSE; ANTIGEN EXPRESSION; CLINICAL PROTOCOL; DRUG DESIGN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LETTER; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINE PRODUCTION; VIRUS IMMUNITY;

EID: 0032080401     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.541     Document Type: Letter

References (0)